The Magnificent Seven represent 34% of the S&P 500 as of August 14, 2025, up from 12.3% in 2015. From 2015 to 2024, these seven companies achieved a 697.6% return, outperforming the S&P 500. In 2025, ...

Not all U.S. value portfolios are created equal. Many are methodology-dependent allocations that produce exposures drastically different from one another, despite being nominally branded as value.

The Value ETF is a wealth compounder first and a passive income tool second. The ETF can be an effective tool for investors who don’t want to amplify their exposure to mega-cap growth stocks. This ...

Our Mission The field of bioinformatics is powered by a vast and ever-growing ecosystem of software tools. For newcomers and seasoned researchers alike, navigating this landscape to find, compare, and ...

After a first half that saw Publicis Groupe snap up six companies around the world, the advertising giant is continuing its acquisitive streak with its first health-focused buyout of the year.

Publicis Group is expanding its network once again, this time with the acquisition of p-value Group — a full service medical communications group. The healthcare agency announced the acquisition ...

Publicis Health announced today its “intent to acquire” p-value Group, a medical communications group. Financial terms of the proposed deal were not disclosed. Headquartered in Cedar Knolls, NJ, the ...

Thanks to Taras-P interceptors, Ukrainian forces have successfully taken down 258 high-value Russian drones. The Serhiy Prytula Charity Foundation reports that seventeen units of the Ukrainian Defense ...

Department of Cellular and Molecular Pharmacology and Physiology (M.S., B.C.B.), University of Rochester School of Medicine and Dentistry, NY. Department of Medicine ...

Several prominent foundation models are employed to enhance our understanding of high-throughput biological data, followed by a discussion on the application of prediction and generation models across ...